Pricing Log in Create free account

aTyr Pharma, Inc. (ATYR) vs MARKER THERAPEUTICS, INC. (MRKR)

aTyr Pharma, Inc. and MARKER THERAPEUTICS, INC. are both Biotechnology companies. aTyr Pharma, Inc. and MARKER THERAPEUTICS, INC. are of similar size ($14.9M and $14.8M). aTyr Pharma, Inc. grew revenue faster over the last twelve months: 6.78% against −46.2%. Across the 15 metrics below, MARKER THERAPEUTICS, INC. leads on 8 and aTyr Pharma, Inc. on 7.

Valuation

Metric ATYR MRKR Biotechnology median
P/E n/m n/m 10.60
P/S 1.38 5.01 9.40
P/B 0.32 1.46 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.61 n/m 0.66
EV/Sales (3.49) 1.88 9.02
Earnings yield (397.17%) (49.75%) (32.88%)
Free cash flow yield (355.97%) (123.23%) (23.13%)

Profitability

Metric ATYR MRKR Biotechnology median
Gross margin 1.72% 134.12% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (98.67%) (76.87%) (51.96%)
Return on assets (70.97%) (59.33%) (46.06%)
Return on invested capital 0.00% (566.75%) 0.00%

Growth

Metric ATYR MRKR Biotechnology median
Revenue growth (TTM) 6.78% (46.19%) 6.76%
EPS growth (last fiscal year) 7.54% 33.61% 29.88%
Revenue growth, 5-year CAGR (14.75%) 50.02% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ATYR MRKR Biotechnology median
Debt to equity 0.00 0.07 0.00
Current ratio 5.12 6.03 4.97
Net debt to EBITDA 1.01 1.32 1.01

Dividend

Metric ATYR MRKR Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ATYR MRKR Biotechnology median
Market cap 14.78m 14.93m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack